Figure 4. Patient with γ-δ subtype peripheral T-cell lymphoma enrolled in a Phase II trial.
The patient had partial remission after two cycles and remained in the study for an additional eight cycles.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.